Growth Metrics

LivaNova (LIVN) Equity Income (2015 - 2026)

LivaNova recorded quarterly Equity Income of -$851000.0 in Q1 2026, down 8410.0% quarter-over-quarter from -$10000.0 in Q4 2025, and down 4155.0% year-over-year from $20986.4 in Q1 2025.

LivaNova's Equity Income history runs 11 years deep, the most recent figure standing at -$851000.0 for Q1 2026.

  • In Q1 2026, Equity Income fell 4155.0% year-over-year to -$851000.0; the TTM figure through Mar 2026 stood at -$882000.0 (down 7250.0% YoY), while the FY2025 annual figure was -$51000.0, down 183.33% from the prior year.
  • Equity Income came in at -$851000.0 for Q1 2026 at LivaNova, down from -$10000.0 in the prior quarter.
  • In the past five years, Equity Income ranged from a high of $57000.0 in Q3 2022 to a low of -$851000.0 in Q1 2026.
  • A 5-year average of -$67312.5 and a median of -$26500.0 in 2023 frame the typical range for Equity Income.
  • Across the five-year window, Equity Income soared 303.57% in 2022 and sank 4155.0% in 2026, its largest moves.
  • LivaNova's Equity Income stood at -$29000.0 in 2022, then jumped by 41.38% to -$17000.0 in 2023, then jumped by 317.65% to $37000.0 in 2024, then tumbled by 127.03% to -$10000.0 in 2025, then tumbled by 8410.0% to -$851000.0 in 2026.
  • According to Business Quant data, Equity Income over the past three periods registered -$851000.0, -$10000.0, and -$13000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Equity Income (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn -
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn -
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn -
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn -
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn -
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn -
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn -
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn -
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn -
10 LivaNova 4.03 Bn 3.45 Bn 243.75 Mn -851,000.00

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -851,000.00
Dec 31, 2025 -10,000.00
Sep 30, 2025 -13,000.00
Jun 30, 2025 -8,000.00
Mar 31, 2025 -20,000.00
Sep 30, 2024 37,000.00
Jun 30, 2024 -29,000.00
Mar 31, 2024 -26,000.00
Dec 31, 2023 -17,000.00
Sep 30, 2023 -32,000.00
Jun 30, 2023 -28,000.00
Mar 31, 2023 -27,000.00
Dec 31, 2022 -29,000.00
Sep 30, 2022 57,000.00
Jun 30, 2022 -42,000.00
Mar 31, 2022 -39,000.00
Dec 31, 2021 -39,000.00
Sep 30, 2021 -28,000.00
Jun 30, 2021 -41,000.00
Mar 31, 2021 -40,000.00
Dec 31, 2020 -43,000.00
Sep 30, 2020 -48,000.00
Jun 30, 2020 -44,000.00
Mar 31, 2020 -129,000.00
Dec 31, 2018 -17,000.00
Jun 30, 2018 -265,000.00
Mar 31, 2018 -362,000.00
Dec 31, 2017 -214,000.00
Sep 30, 2017 -407,000.00
Jun 30, 2017 -14.10 Mn
Mar 31, 2017 -2.00 Mn
Dec 31, 2016 703,000.00
Sep 30, 2016 -13.13 Mn
Jun 30, 2016 -3.54 Mn
Mar 31, 2016 -2.72 Mn
Dec 31, 2015 -2.22 Mn